Lipitor Is Medicare Rx Marketing Tool For Drug Plans, Pfizer Says
Executive Summary
Pfizer's Lipitor is viewed by Medicare prescription drug plans as a marketing tool with which to attract beneficiaries, U.S. Pharmaceuticals President Pat Kelly said on a second quarter earnings call July 20
You may also be interested in...
Welcome To Medicare: Pfizer Sees Part D As Key To Rebirth
The Medicare prescription drug benefit will be a key factor for energizing Pfizer's growth, CEO Hank McKinnell indicated during the Morgan Stanley Pharmaceutical CEOs Unplugged conference in New York Jan. 4
Welcome To Medicare: Pfizer Sees Part D As Key To Rebirth
The Medicare prescription drug benefit will be a key factor for energizing Pfizer's growth, CEO Hank McKinnell indicated during the Morgan Stanley Pharmaceutical CEOs Unplugged conference in New York Jan. 4
Pfizer Medicare Part D Formulary Placement: Bundled Up, Or Out In The Cold?
Pfizer appears to have taken an all-or-nothing approach to negotiating formulary positioning for its products in Medicare Part D prescription drug plans, according to an analysis by "The Pink Sheet" of plan formularies